Roundtable Discussion on COVID-19
Thursday, May 7, 2020 | 5:00 p.m. ET
Virtual Event
Join us for a live Q&A event with John Pottage '74, Christina Farrell '90, and David Beier '70. Hear from three health care experts in this special webinar. You can submit your questions in advance or throughout the webinar.
Bio for David Beier '70:
David Beier, JD is a Managing Director of Bay City Capital and has been with the firm since 2013. He is a globally recognized leader in health care policy, pricing, intellectual property, government affairs, regulatory affairs, health care economics, and product commercialization. In addition, having spent two decades as part of the senior management teams for Amgen and Genentech, the two largest biotechnology companies in the world, he contributes invaluable perspective regarding strategy for entrepreneurial biotechs, the needs of potential acquirers, and the global health care industry in general.
Mr. Beier served in the White House as the Chief Domestic Policy Advisor to Vice President Al Gore during the Clinton Administration. He has served as an appointee of President Clinton, on the Institute of Medicine panel on the Future of Health and Human Services, and as an advisor to the President’s Council of Advisors on Science and Technology. Mr. Beier was also formerly a partner in international law firm Hogan and Hartson (now Hogan Lovell’s) and was formerly Counsel to the US House of Representatives Committee on the Judiciary. In addition, he previously served on the study committee of the National Academy of Sciences on genome editing.
He has testified before Congress and the Federal Trade Commission, has written numerous law review articles and technical legal works, is regularly invited to author expert OpEds on health care, and has contributed to books on topics ranging from intellectual property, trade, privacy and justice issues.
Mr. Beier is a member of the Board of Directors of the California Life Science Association, and the University of California San Francisco Benioff Children’s Hospitals. He currently serves as an appointee of Governor Brown on the California State Government Organization and Economy Commission. He is also an advisor to the Parker Institute on Cancer Immunotherapy. In addition, Mr. Beier is a Senior Fellow at the USC Schaeffer Center for Health Policy & Economics and serves on the Board of Directors at Arcus Biosciences and Infinity Pharmaceuticals, Inc.
He received his JD from Albany Law School at Union University and his undergraduate degree at Colgate University. He is admitted to practice law in New York and the District of Columbia.
Bio for Christina Farrell '90:
Christina Farrell is the deputy commissioner for external affairs at the New York City Department of Emergency Management. She oversees the agency’s communications and interactions with the press, elected officials and the private sector. She also manages Ready New York, New York City’s public education campaign focused on emergency preparedness, the Community Emergency Response Teams (CERT) program, community network building among the city’s diverse neighborhoods and language access. She previously served as the director of the NYC Mayor’s Office of Grants Administration and started her career as a legislative aide for Congressman Dante Fascell. She holds a Master of Public Administration from the University of North Carolina at Chapel Hill and a Bachelor of Arts in International Relations with a minor in Economics from Colgate University.
Bio for John Pottage '74:
John C. Pottage, Jr., M.D. served as Senior Vice President and Chief Scientific and Medical Officer of ViiV Healthcare from November 2009 to October 2019, where he oversaw research and development, regulatory, safety and medical affairs. Prior to joining ViiV Healthcare, Dr. Pottage served as Senior Vice President and Head of the Infectious Disease Medicine Development Center at GlaxoSmithKline from September 2008 to November 2009, and prior to that, from June 2007 to September 2008, as Vice President of Global Clinical Development of Antivirals at GlaxoSmithKline. From May 2002 to May 2007, Dr. Pottage served as Chief Medical Officer and Senior Vice President of Drug Development of Achillion Pharmaceuticals.
Prior to Achillion Pharmaceuticals, Dr. Pottage served as Medical Director of Vertex Pharmaceuticals, and in various clinical and academic positions at Rush University Medical Center. Dr. Pottage currently is a non-executive Director of Spero Therapeutics in Cambridge, MA and also serves on the advisory board of Medicines for Malaria Venture in Geneva, Switzerland.
He received his A.B. in biology from Colgate University and his M.D. from Saint Louis University School of Medicine. He is Board certified in Internal Medicine and Infectious Diseases by the American Board of Internal Medicine.
Hear from a virologist and health care policy expert, among others, in this special webinar. You can submit your questions in advance or throughout the webinar.
Free to attend
Please enter a whole number
Would you please consider an optional gift of $13 or more to the Colgate Fund to support students, faculty, and community?
$
Please enter a positive number
Live Q&A on COVID-19:
Individual
0
$Free to attend